By Colin Kellaher Amylyx Pharmaceuticals on Thursday said it is pulling its Relyvrio/Albrioza drug for amyotrophic lateral sclerosis, or ALS, from the market and slashing its workforce by 70%..
Amylyx to Pull ALS Drug Relyvrio From US, Canada Markets After Phase III Fail biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.